Citations refer to the original publication, not to a Scieee localized version.
Ordóñez, J. L., Amaral, A. T., Carcaboso, Á. M., Herrero-Martin, D., García-Macías, M. D. C., Sevillano, V., & Álava Casado, E. D. (2017). The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin. Impact Journals LLC. https://doi.org/10.18632/oncotarget.4303
Ordóñez, José Luis, et al. The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin. Impact Journals LLC, 2017. https://doi.org/10.18632/oncotarget.4303.
Ordóñez, José Luis, Ana Teresa Amaral, Ángel M. Carcaboso, David Herrero-Martin, María del Carmen García-Macías, Vicky Sevillano, and Enrique de Álava Casado. The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin. Impact Journals LLC, 2017. https://doi.org/10.18632/oncotarget.4303.
Ordóñez, J. L. et al. (2017) The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin. Impact Journals LLC. Available at: https://doi.org/10.18632/oncotarget.4303.
J. L. Ordóñez et al., “The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin,” Impact Journals LLC, 2017, doi: 10.18632/oncotarget.4303.
@misc{ordonez2017parp,
author = {Ordóñez, José Luis and Amaral, Ana Teresa and Carcaboso, Ángel M. and Herrero-Martin, David and García-Macías, María del Carmen and Sevillano, Vicky and Álava Casado, Enrique de},
title = {The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin},
year = {2017},
publisher = {Impact Journals LLC},
doi = {10.18632/oncotarget.4303},
url = {https://doi.org/10.18632/oncotarget.4303}
}
The source metadata has no journal, volume or pages. Add them from the original publication if your citation needs them.
